吉贝尔：关于获得发明专利的自愿性披露公告

Core Viewpoint - The company, Jibeier, has recently received a patent certificate from the National Intellectual Property Administration for an invention related to "a paclitaxel derivative and its preparation method and application" [2] Group 1 - The patent signifies a potential advancement in the pharmaceutical sector, particularly in cancer treatment, as paclitaxel is a well-known chemotherapeutic agent [2] - The issuance of this patent may enhance the company's competitive position in the market by protecting its intellectual property and potentially leading to new product developments [2] - This development could attract investor interest, as patents often indicate future revenue streams and innovation capabilities [2]